These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 24633997)
21. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Chen Y; Stankovic R; Cullen KM; Meininger V; Garner B; Coggan S; Grant R; Brew BJ; Guillemin GJ Neurotox Res; 2010 Aug; 18(2):132-42. PubMed ID: 19921535 [TBL] [Abstract][Full Text] [Related]
22. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice. Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279 [TBL] [Abstract][Full Text] [Related]
23. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. Steiner J; Bogerts B; Sarnyai Z; Walter M; Gos T; Bernstein HG; Myint AM World J Biol Psychiatry; 2012 Oct; 13(7):482-92. PubMed ID: 21707463 [TBL] [Abstract][Full Text] [Related]
24. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Heyes MP; Achim CL; Wiley CA; Major EO; Saito K; Markey SP Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):595-7. PubMed ID: 8973572 [TBL] [Abstract][Full Text] [Related]
25. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Saito K; Markey SP; Heyes MP Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184 [TBL] [Abstract][Full Text] [Related]
26. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes. Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958 [TBL] [Abstract][Full Text] [Related]
27. A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis. Ramírez LA; Pérez-Padilla EA; García-Oscos F; Salgado H; Atzori M; Pineda JC Biomedica; 2018 Sep; 38(3):437-450. PubMed ID: 30335249 [TBL] [Abstract][Full Text] [Related]
28. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588 [TBL] [Abstract][Full Text] [Related]
30. The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain. Mazarei G; Budac DP; Lu G; Lee H; Möller T; Leavitt BR Exp Neurol; 2013 Nov; 249():144-8. PubMed ID: 23994717 [TBL] [Abstract][Full Text] [Related]
31. Etiological classification of depression based on the enzymes of tryptophan metabolism. Fukuda K BMC Psychiatry; 2014 Dec; 14():372. PubMed ID: 25540092 [TBL] [Abstract][Full Text] [Related]
32. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346 [TBL] [Abstract][Full Text] [Related]
34. The effect of minocycline on indolamine 2, 3 dioxygenase expression and the levels of kynurenic acid and quinolinic acid in LPS-activated primary rat microglia. Bahrami Z; Firouzi M; Hashemi-Monfared A; Zahednasab H; Harirchian MH Cytokine; 2018 Jul; 107():125-129. PubMed ID: 29246652 [TBL] [Abstract][Full Text] [Related]
36. Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase. Landfried K; Zhu W; Waldhier MC; Schulz U; Ammer J; Holler B; Wolff D; Edinger M; Peter K; Kreutz M; Andreesen R; Oefner PJ; Holler E Blood; 2011 Dec; 118(26):6971-4. PubMed ID: 22039265 [TBL] [Abstract][Full Text] [Related]
37. Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study. Kruse JL; Cho JH; Olmstead R; Hwang L; Faull K; Eisenberger NI; Irwin MR Psychoneuroendocrinology; 2019 Nov; 109():104371. PubMed ID: 31325802 [TBL] [Abstract][Full Text] [Related]
38. Kynurenine pathway metabolites modulated the comorbidity of IBD and depressive symptoms through the immune response. Lai W; Huang Z; Li S; Li XG; Luo D Int Immunopharmacol; 2023 Apr; 117():109840. PubMed ID: 36827928 [TBL] [Abstract][Full Text] [Related]